Obesity is a multifactorial condition involving both genetic predisposition and environmental influences. Genetic susceptibility, particularly involving the melanocortin-4 receptor (MC4R) gene, has shown a significant impact. Specifically, the MC4R rs17782313 polymorphism has been linked to an increased obesity risk across different populations. This study systematically reviewed existing literature and performed a meta-analysis to investigate the relationship between MC4R rs17782313 variants (heterozygous and homozygous forms) and obesity risk. Relevant studies were systematically identified through searches in the PubMed, Medline, and Cochrane databases, focusing on research examining the relationship between the MC4R rs17782313 polymorphism and obesity susceptibility. Seven eligible studies were included for meta-analysis. Data extraction was conducted carefully, and analysis was performed using a random-effects model (REM) to address variability between studies. Odds ratios (OR) with 95% confidence intervals (CI) were calculated to determine the obesity risk associated with heterozygous (TC) and homozygous (CC) genotypes compared to non-carriers. The analysis revealed that carriers of the TC/CC genotype for the MC4R rs17782313 polymorphism had a significantly higher obesity risk, with a 21% increase compared to non-carriers (OR = 1.21; 95% CI = 1.03–1.42; p = 0.02). The random-effects model indicated a consistent association across different populations, demonstrated by moderate heterogeneity (I² = 58%). Additionally, the funnel plot analysis showed symmetrical distribution, suggesting low likelihood of publication bias. The MC4R rs17782313 polymorphism is significantly associated with an elevated obesity risk of approximately 21% in individuals with either heterozygous or homozygous variants. These results highlight the importance of genetic factors in obesity development and suggest potential avenues for genetic-based therapeutic approaches.
Copyrights © 2026